HIDEKAZU TSUJISHIMA,HIROAKI SAWAMOTO,HIROAKI SHITAMA,KENJI MOROKUMA,KUNIO SARUTA,NORIMITSU HAYASHI,OSAMU SAKURAI,RITSUO IMASHIRO,TAKASHI GOI
申请号：
BR112013014966
公开号：
BR112013014966A2
申请日:
2011.12.16
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
This is to provide a continuous arycyclic compound having a DGAT1 inhibitory activity, and useful for prophylaxis and/or treatment of obesity or hyperlipidemia caused by obesity, hypertriglyceridemia, lipid metabolism disorder, fatty liver, hypertension, arteriosclerosis, diabetes, etc., as well as to provide a DGAT1 inhibitor comprising the continuous arycyclic compound or a pharmaceutically acceptable salt thereof as an effective ingredient. Disclosed is the continuous arycyclic compound is represented by the formula: wherein the substituents in the formula are the same as defined in the specification, or a pharmaceutically acceptable salt thereof.
